TBC1D1 and central nervous system cancer: Immunohistochemical data from the HPA project (https://www.proteinatlas.org/) suggested that TBC1D1 protein levels were increased in low-grade and high-grade glioma tissues compared with those in normal cerebral cortex tissues (Figure 3A–3C).